SHA:605199 Revenue

Hainan Huluwa Pharmaceutical Group had revenue of 175.05M CNY in the quarter ending September 30, 2025, with 21.87% growth. This brings the company's revenue in the last twelve months to 1.06B, down -31.37% year-over-year. In the year 2024, Hainan Huluwa Pharmaceutical Group had annual revenue of 1.41B, down -21.26%.

Revenue (ttm)

1.06B

Revenue Growth

-31.37%

P/S Ratio

2.66

Revenue / Employee

505.79K

Employees

2,103

Market Cap

2.83B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.41B	-381.64M	-21.26%
Dec 31, 2023	1.80B	280.14M	18.49%
Dec 31, 2022	1.52B	161.25M	11.91%
Dec 31, 2021	1.35B	192.09M	16.53%
Dec 31, 2020	1.16B	-144.21M	-11.04%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Enwei Pharmaceutical	888.64M
Shaanxi Kanghui Pharmaceutical	513.23M
Guhan Pharmaceutical Group	351.79M
Zhejiang Shapuaisi Pharmaceutical	475.19M
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	914.65M
Hainan Shuangcheng Pharmaceuticals	216.15M
Ginwa Enterprise (Group)	550.44M
Chengdu huasun technology group Inc. , LTD.	658.28M

Revenue Rankings